The FDA has given Paragonix Technologies 510(k) clearance for its Sherpa Pak Cardiac Transport System to be used in preserving donor hearts in transit for as long as four hours. The device uses oxygenated perfusion and cold storage technology, and the company hopes it will eventually be cleared to keep donor hearts alive for up to 12 hours.
Paragonix's donor heart transport system wins FDA nod
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||